Table 1 Postmortem human brains used in the study of sPLA2-IIA expression
From: Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease
Cases | Clinical Diagnosis | Gender | Age (years) | PMI (hours) | Type of Study | Brain Region |
|---|---|---|---|---|---|---|
1 | ND | M | 78 | 2.7 | IHC | ITG |
2 | ND | M | 81 | 2.7 | IHC | I TG |
3 | ND | M | 69 | 2.2 | IHC | HPC, ITG |
4 | ND | M | 84 | 2.5 | IHC | HPC, ITG |
5 | ND | M | 78 | 1.7 | IHC | HPC, ITG |
6 | ND | M | 94 | 3.0 | RNA | HPC, CB |
7 | ND | M | 85 | 3.2 | RNA | HPC, CB |
8 | ND | F | 85 | 2.5 | RNA | HPC, CB |
9 | ND | F | 86 | 2.0 | RNA | HPC, CB |
10 | ND | F | 88 | 3.0 | RNA | HPC, CB |
11 | ND | F | 94 | 2.5 | RNA | HPC, CB |
12 | ND | F | 86 | 2.5 | RNA | HPC, CB, |
13 | ND | F | 83 | 2.5 | RNA | HPC, CB |
14 | ND | F | 94 | 2.3 | RNA | HPC, CB, |
15 | ND | F | 78 | 2.8 | IHC | ITG |
| Â | Â | Â | Â | Â | RNA | HPC, CB |
16 | ND | F | 88 | 3.5 | RNA | HPC, CB |
17 | AD | M | 86 | 3.0 | IHC | ITG |
18 | AD | M | 87 | 3.0 | IHC | HPC |
| Â | Â | Â | Â | Â | RNA | HPC, CB |
19 | AD | M | 79 | 2.0 | IHC | HPC |
| Â | Â | Â | Â | Â | RNA | HPC, CB |
20 | AD | M | 94 | 3.8 | IHC | ITG |
21 | AD | M | 92 | 2.0 | IHC | ITG |
22 | AD | F | 89 | 3.0 | IHC | HPC |
| Â | Â | Â | Â | Â | RNA | HPC, CB |
23 | AD | F | 80 | 2.3 | IHC | HPC, ITG |
24 | AD | F | 85 | 1.7 | RNA | HPC, CB |
25 | AD | F | 95 | 3.2 | RNA | HPC, CB |
26 | AD | F | 91 | 3.0 | RNA | HPC, CB |
27 | AD | F | 89 | 2.3 | RNA | HPC, CB |
28 | AD | F | 97 | 1.5 | IHC | ITG |
29 | AD | F | 64 | 3.2 | IHC | ITG |
30 | AD | F | 77 | 2.8 | IHC | ITG |
31 | AD | F | 85 | 2.3 | IHC | HPC |
32 | AD | F | 90 | 3.0 | RNA | HPC, CB |